ursodeoxycholic acid has been researched along with Eye Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kiss, LS; Lakatos, L; Lakatos, PL; Peyrin-Biroulet, L; Schoepfer, A; Vavricka, S | 1 |
| Adler, G; Reinshagen, M | 1 |
2 review(s) available for ursodeoxycholic acid and Eye Disorders
| Article | Year |
|---|---|
Treatment of extraintestinal manifestations in inflammatory bowel disease.
Topics: Anti-Inflammatory Agents; Anticoagulants; Arthritis; Bone Density Conservation Agents; Cholagogues and Choleretics; Cholangitis, Sclerosing; Eye Diseases; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Osteoporosis; Skin Diseases; Ursodeoxycholic Acid; Venous Thromboembolism | 2012 |
[Extraintestinal manifestations].
Topics: Amyloidosis; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Cholelithiasis; Cohort Studies; Controlled Clinical Trials as Topic; Crohn Disease; Cross-Sectional Studies; Drug Therapy, Combination; Eye Diseases; Humans; Immunosuppressive Agents; Joint Diseases; Kidney Calculi; Kidney Diseases; Liver Diseases; Longitudinal Studies; Lung Diseases; Nervous System Diseases; Osteoporosis; Pancreatitis; Placebos; Prospective Studies; Retrospective Studies; Risk; Risk Factors; Skin Diseases; Thromboembolism; Ursodeoxycholic Acid | 2003 |